Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.95 - $27.04 $4.32 Million - $6.9 Million
-255,032 Reduced 28.34%
644,968 $17.4 Million
Q1 2024

May 15, 2024

SELL
$11.38 - $19.03 $1.14 Million - $1.9 Million
-100,000 Reduced 10.0%
900,000 $16.5 Million
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $5.03 Million - $12.6 Million
800,000 Added 400.0%
1,000,000 $12.3 Million
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $749,500 - $1.63 Million
50,000 Added 33.33%
200,000 $3 Million
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $4.46 Million - $6.92 Million
150,000 New
150,000 $4.87 Million
Q1 2020

May 15, 2020

SELL
$23.16 - $47.8 $2.32 Million - $4.78 Million
-100,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$31.65 - $46.94 $1.6 Million - $2.37 Million
-50,500 Reduced 33.55%
100,000 $3.25 Million
Q2 2019

Aug 14, 2019

BUY
$32.5 - $49.12 $4.89 Million - $7.39 Million
150,500 New
150,500 $7.29 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.